other material
confidence high
sentiment neutral
materiality 0.60
Agilent moves Cell Analysis Div. to D&G segment; recasts FY21-23 segment data
AGILENT TECHNOLOGIES, INC.
- Cell Analysis Division moved from LSAG to Diagnostics & Genomics Group (DGG) effective Q1 FY24.
- Recast segment financials for FY21-23: LSAG FY23 revenue $3.51B, DGG $1.755B, CrossLab $1.568B.
- LSAG FY23 operating margin 29.9%; DGG 20.7%; CrossLab 29.5%.
- Prior periods restated; new reporting structure begins with quarter ending Jan 31, 2024.